jump to navigation

American Cancer Society Awards David Sabatini of Whitehead Institute with Five-Year Renewable Research Professorship 10/03/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences, Nonprofit.
Tags: , , ,
add a comment

whitehead-institute-client-logo-sm-m0055040xb1386

David Sabatini, MD, PhD, of MBBP client Whitehead Institute for Biomedical Research, was awarded the prestigious five-year renewable American Cancer Society Research Professorship. The award is part of a larger approval of funding for 78 research and training grants totaling $39,836,250.

According to the press release, Sabatini “looks to maximize the precise targeting of cancer drugs into the relevant tissues by exploiting the specificity of transport proteins embedded in lipid membranes on the surface and within cells. If successful, this approach could address a major challenge in drug delivery and could lead to safer and more effective cancer therapies.”

Congratulations to Mr. Sabatini. More information can be found in the press release.

Skelmet Creates Custom-Built Sport Sunglasses Using 3-D Technology 09/14/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Computer Software & Hardware, Manufacturing, Retail & Service.
Tags: , , ,
add a comment

MBBP client Skelmet’s Falcon 1 sport sunglasses are custom-built to perfectly fit your face and are ideal for athletes. They are created using 3-D scanning and printing technology and Skelmet’s design algorithm. The order process for the glasses includes a 3-D scan of the face, which is then entered into Skelmet’s A.I. Fit design system, after which the glasses are 3-D printed.

Skelmet’s cofounder Rain Wang, a former triathlete, created the company from her growing frustration of the fit of mass-produced sports products. Skelmet mass customizes all of its products so that consumers can find their individual fit.

To learn more about Skelmet’s Falcon 1 sunglasses, read the full article in the Boston Globe.

TechCrunch Names Escher Reality One of of Top 7 Startups at Y Combinator S’17 Demo Day 08/29/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Computer Software & Hardware, Games & Interactive Entertainment.
Tags: , , ,
add a comment

TechCrunch named MBBP client Escher Reality one of the top seven startups from the Y Combinator Summer 2017 Demo Day part 1. Y Combinator’s Demo Day is an opportunity for the companies that participated in its intensive pitch preparation program to present their company to investors.

Escher Reality is an augmented reality data platform that collects AR mapping data from camera phone videos and allows other developers to build on the augmented reality experience. TechCrunch picked them as one of their top seven startups because:

AR is becoming the next big trend in consumer software. But the physical world is vast, and both developers and platforms will need assistance getting mapping data for everywhere.”

Congratulations to Escher Reality on this recognition. More information can be found on TechCrunch.

MBBP’s Life Sciences Vector Newsletter, Summer 2017 08/24/2017

Posted by Morse Barnes-Brown Pendleton in Client News.
Tags: , , , , , , ,
add a comment

extOur Life Sciences team has published the Summer 2017 edition of its Vector newsletter. Below you will find brief descriptions of the news and articles included in the publication. Read the full newsletter for more information.

CORPORATE PARTNER MIKE JABBAWY PARTICIPATING ON SHOOBX STARTUP PANEL

On September 26, corporate partner Mike Jabbawy will take part in the panel “How to Start a Startup.” The panel is part of Shoobx’s Startup Series, which features real life stories from startup founders, investors, and community members. More information and how to register for the event can be found on page 1.

INTELLECTUAL PROPERTY ATTORNEY AMANDA SCHREYER JOINS MBBP AS COUNSEL

Intellectual Property attorney Amanda Schreyer joined the firm as Counsel. Amanda focuses her practice on licensing and strategic alliances; trademarks and copyrights; and privacy and data security. Read more about Amanda’s practice.

MORE MONEY FOR LIFE SCIENCES?

A new legislative proposal to provide a five-year, $500 million life sciences initiative was recently announced by Governor Charlie Baker. This initiative would extend the current 10-year, $1 billion initiative that is set to expire at the end of the next fiscal year and would continue to be managed by the Massachusetts Life Sciences Center. More information about the proposal can be found on page 1.

SANDOZ INC. v. AMGEN INC.: SUPREME COURT CLARIFIES BPCIA PROVISIONS

On June 12, 2017, the United States Supreme Court issued its first ruling on two key provisions of the Biologics Price Competition and Innovation Act (“BPCIA”) concerning the resolution of patent infringement suits in connection with the submission to the Food and Drug Administration (“FDA”) of applications to commercialize biosimilars in the United States. Read more about the case implications.

LIFE TECHNOLOGIES CORP. v. PROMEGA CORP.

On February 22, 2017, the Supreme Court issued its decision in Life Technologies Corp. v. Promega Corp., a case focused on interpreting the patent infringement statute which creates liability for exporting a component of a patented invention. Read the full article for more information.

TC HEARTLAND LCC v. KRAFT FOODS GROUP BRANDS LLC

In TC Heartland LLC v. Kraft Foods Group Brands LLC, the Supreme Court unanimously held that 28 U.S.C. § 1400(b) is the exclusive provision controlling venue in patent cases, and that under this provision a corporation “resides” only in the state of incorporation. Continue reading for more information about the case.

THE MINUTIAE OF CORPORATE MINUTES?

Young entrepreneurs and corporate associates of emerging companies frequently ask: “How detailed should Board of Directors meetings’ minutes be?” The short answer is: Do not delve into minutiae, other than precision for approval of equity issuances, option grants and material contracts. More guidance on corporate minutes can be found starting on page 4.

CLIENT SPOTLIGHT: CRISTCOT LLC

Cristcot LLC is a global life sciences company focused on the development and commercialization of unique drug delivery systems, combination products, and specialty drug formulations that improve the quality of patient care. Read the full spotlight on page 6.

Inc. Magazine Includes Dane Street on List of Fastest Growing Private Companies for 5th Consecutive Year 08/22/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: , ,
add a comment

Dane Street Client Logo (M0739750xB1386)For the fifth consecutive year, MBBP client Dane Street has been included on Inc. Magazine’s exclusive List of Fastest Growing Private Companies in America. Inc. Magazine lists Dane Street’s 3-year growth as 141%. Dane Street provides Independent Medical Examination and Peer Review services to the auto, disability, group health, pharmacy, and workers’ compensation industries.

Congratulations to our client on this well-deserved recognition.

Lisa McKerracher of BioAxone BioSciences Joins Advisory Panel for Christopher Reeve Foundation 08/10/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: , , ,
add a comment

Lisa McKerracher, CEO of MBBP client BioAxone BioSciences, has accepted the role of Consortium Advisory Panelist for the Christopher & Dana Reeve Foundation. Dr. McKerracher will “direct the foundation’s focus toward the identification, development, and translation of potential Spinal Cord Injury (SCI) therapies into the clinic.”

BioAxone BioSciences is a clinical-state biopharmaceutical company developing regenerative therapeutic drugs based on a deep understanding of axon regeneration and neuronal signaling pathways. The Christopher & Dana Reeve Foundation is dedicated to advancing quality of life and discovering cures for spinal cord injury.

More information can be found in the full release.

David Sabatini To Be Awarded 2017 Dickson Prize in Medicine 08/10/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: , , ,
add a comment

whitehead-institute-client-logo-sm-m0055040xb1386Biologist David Sabatini of MBBP client Whitehead Institute will receive the University of Pittsburgh’s 2017 Dickson Prize in Medicine. The Dickson Prize in Medicine is awarded annually to a leading American investigator who is engaged in innovative, paradigm-shifting biomedical research.

Sabatini discovered mTOR, a key cellular regulatory metabolic pathway. In addition to being a member of the Whitehead Institute for Biomedical Research, he teaches biology at MIT and is a senior associate at the Broad Institute of MIT and Harvard University. He is also a member of the MIT Koch Institute for Integrative Cancer Research and is a Howard Hughes Medical Institute investigator.

The award will be presented to Sabatini in October at the University of Pittsburgh’s Science 2017 event. More information can be found on the University’s Dickson Prize in Medicine page.

Bach Pharma’s GVT Drug Reverses Brain Dysfunction, Report Shows 08/09/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: , , , ,
add a comment

Firm client Bach Pharma’s GVT drug successfully reverses brain dysfunction and therefore may be an effective treatment for victims of Gulf War Illness (GWI), according to a Department of Defense report on the results of a multi-year pre-clinical study conducted by Ashok K. Shetty, PhD, Associate Director and Professor at the Institute for Regenerative Medicine at the College of Medicine at Texas A&M University System. GWI is prevalent among servicemen and women from the Gulf War and can cause memory impairment, depression, and anxiety. The study was conducted under a grant from the DoD.

GVT has proven both neuro-protective and neuro-generative and could potentially act as a therapeutic treatment for chemical poisoning associated disorders. The fact that GVT regenerates stem cells and neurons was an unexpected finding of this study. Based on these results, Dr. Shetty has established a collaboration with Dena Davidson, PhD, deputy director of research at the Veterans Integrated Service Network (VISN) 17 Center of Excellence for Research on Returning War Veterans to pursue clinical trials in GWI patients.

Congratulations to our client, Bach Pharma, on this extraordinary achievement. Read the full press release for more information.

NIH/SBIR Grant Awarded to Firm Client BioAxone BioSciences for BA-1049 Inhibitor Research 08/03/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: , ,
add a comment

The National Institutes of Health (NIH), Small Business Innovation Research (SBIR), and National Institute of Neurological Disorders and Stroke have awarded firm client BioAxone BioSciences, Inc. with a $1.5 million grant. The grant is for continued research for BioAxone’s Rho Kinase 2 (ROCK2) inhibitor, BA-1049, a transformative drug to treat cerebral cavernous malformation, a serious genetic disease.

BioAxone is a clinical-state biopharmaceutical company developing regenerative therapeutic drugs based on a deep understanding of axon regeneration and neuronal signaling pathways.

Congratulations to our client on receiving the grant and on their revolutionary drug research. For more information, read the full release.

Firm Clients Sheprd and iZotope Are Finalists in MassTLC Leadership Awards 07/27/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Computer Software & Hardware, Internet and E-Commerce, Telecommunications & Networking.
Tags: , , ,
add a comment

Firm clients Sheprd and iZotope are among the 2017 MassTLC Technology Leadership Awards finalists. The awards, presented by the Mass Technology Leadership Council, are comprised of individual and company categories, including CEO of the Year, Emerging Executive of the Year, Emerging Company of the Year, Cutting Edge Technology of the Year, and Technology for a Better Tomorrow, among others.

Sheprd and iZotope are both finalists in the Innovative Tech of the Year: Consumer category. The winners will be announced at the MassTLC Leadership Awards Gala on September 14th.

Congratulations and good luck to our clients, Sheprd and iZotope.

BioAxone BioSciences Peer-Reviewed Research Article Published in Frontiers Journal Series 07/20/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: , ,
add a comment

Firm client BioAxone BioSciences announced that its peer-reviewed research article on axon regeneration was published in Frontiers Journal Series, Frontiers in Molecular Neuroscience. The article “MAG, Myelin and Overcoming Growth Inhibition in the CNS” was written by BioAxone’s CEO Lisa McKerracher, Ph.D. and Kenneth Rosen, Ph.D., VP of Research. Frontiers in Molecular Neuroscience publishes rigorously peer-reviewed research that aims to identify key molecules underlying the structure, design, and function of the brain across all levels.

BioAxone is a clinical-state biopharmaceutical company developing regenerative therapeutic drugs based on a deep understanding of axon regeneration and neuronal signaling pathways.

Congratulations to our client on this achievement. For more information, read the press release.

ConforMIS Receives FDA Clearance for iTotal Hip Replacement System 06/27/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences, Medical Devices.
Tags: ,
add a comment

conformis-inc-logoFirm client ConforMIS, Inc. received FDA 510(k) clearance for its primary iTotal Hip replacement system. Chief Executive Officer and President Mark Augusti remarked:

Having treated over 50,000 patients with customized knee replacement implants, ConforMIS brings over a decade of experience in patient-specific technology to the hip replacement market. FDA clearance of iTotal Hip demonstrates the ability to apply our proprietary iFit® image-to-implant technology to other joints. There has been a trend towards personalized healthcare and we believe patients expect and deserve personalized treatment.”

The iTotal Hip replacement system has technology that is similar to that used in ConforMIS’s customized knee implants. The company hopes to improve patient outcomes through customized implants for joint replacements.

Congratulations to our client on this achievement. For more information, read the full announcement.

iSpecimen Unveils Online Biospecimen Marketplace 06/13/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: , ,
add a comment

iSpecimen Logo (M0910032xB1386)Firm client iSpecimen has launched an online biospecimen marketplace for the life sciences industry. The company hopes that the marketplace will alleviate scientists’ difficulty in finding high-quality samples of human material necessary to conduct research.

The marketplace compiles available samples and allows users to search by patient information. Users can then order the corresponding materials.

For more information about the iSpecimen Marketplace, read the full article in the BBJ, or iSpecimen’s press release.

MBBP Clients Included in MassChallenge 2017 Startup Class 05/25/2017

Posted by Morse Barnes-Brown Pendleton in Client News.
Tags: , , , ,
add a comment

logo_mcFirm clients DropZone for Veterans and Skelmet are among the 128 startups that will be a part of this year’s MassChallenge Boston accelerator program. MassChallenge helps the world’s highest-impact and highest-potential startups launch, grow, and make an impact across various industries. The program received more than 1,500 applications this year, and will end with the MassChallenge Boston Awards, where startups will compete for shares of more than $1.5 million in equity-free awards.

DropZone for Veterans is a customizable directory of high-impact veteran benefits including education, employment, family, and health and wellness. Skelmet is revolutionizing the eyewear industry with 3D Fit technology, combining state of the art 3D scanning with 3D printing to automatically measure, design, and produce bespoke sunglasses.

Congratulations to DropZone for Veterans and Skelmet!

Applied BioMath and Northern Biologics to Collaborate on Biotherapeutic Candidate in Oncology 04/21/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Life Sciences.
Tags: , ,
add a comment

Applied BioMath logo (M1064209xB1386)Firm client Applied BioMath, the industry-leader in applying mechanistic modeling to drug research and development, announced a collaboration with Northern Biologics, an innovative antibody discovery and development company. The companies will focus on traditional and mechanistic pharmacokinetic and pharmacodynamics (PK/PD) modeling for a biotherapeutic candidate in oncology. Applied BioMath will leverage both traditional PK/PD models and semi-mechanistic PK/PD models, while Northern Biologics will use this model to strengthen their understanding of the parameters that will determine optimal dosing paradigms.

Congratulations to our client on this new collaboration. For more information, read the full press release.

WatchRx Selected as Top Innovator by AARP and MedCity News 04/19/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Medical Devices, Telecommunications & Networking.
Tags: , , ,
add a comment

WatchRx Logo (M0897830xB1386)Jayanthi Narasimhan, Founder and CEO of firm client WatchRx, has been named a 50+ Innovation Leader by AARP and MedCity News. The honor recognizes the leading innovators of services and products designed to serve the booming 50+ consumer health market.

Those who made the list were selected by their peers by voting. Modernizing patient care to meet the needs of today’s mobile world was a common goal of many of the winners, as well as exceptional creativity in alternative therapies, smart wearables, and product design.

WatchRx was founded from the need of the founders’ to assist their aging parents with managing medications and health conditions remotely for their multiple chronic conditions. The company delivers global award winning products to consumer, telecommunications, and enterprise industries.

Congratulations to all of the winners and to our client, Jayanthi of WatchRx!

Visible Good Advances to Finals in SBANE Innovation Awards 04/12/2017

Posted by Morse Barnes-Brown Pendleton in Client News.
Tags: , ,
add a comment

Visible Good Logo (M0692054xB1386)Visible Good, a firm client, has been selected as a finalist in this year’s SBANE New England Innovation Awards. The Innovation Awards recognize companies that have transformed their innovative ideas into a product or service that delivers proven value to customers. This year’s competition began with 200 companies, and has since been narrowed to twenty.

Visible Good provides shelter to those in need, specifically for humanitarian assistance and disaster relief. We are proud to have them as a client and congratulate them on their place as a finalist!

MBBP Corporate Attorneys Represent Mosse & Mosse Associates in Acquisition of Certain Assets by Risk Strategies Company 04/12/2017

Posted by Morse Barnes-Brown Pendleton in Attorney News, Client News, Corporate, Deal News, MBBP news.
Tags: , ,
add a comment

A team of Morse Barnes Brown Pendleton attorneys, led by Joe Marrow, Dave Czarnecki, Kelly Hinkel and corporate paralegal Yongha Lee, recently represented our client Mosse & Mosse Associates, LLC in a sale of certain assets to Risk Strategies Company. Mosse & Mosse provides its client base with both employee benefits and retirement plan consulting services. Risk Strategies Company, a privately-held, rapidly-growing national insurance brokerage and risk management firm, has expanded its employee benefits practice and expertise through the Mosse & Mosse acquisition. The sale of assets did not include Mosse & Mosse’s benefits business related to municipalities and educational institutions, and MBBP will continue to represent Mosse & Mosse in that on-going enterprise.

Dane Street Selected for Boston Business Journal’s 2017 FAST 50 List 04/05/2017

Posted by Morse Barnes-Brown Pendleton in Client News.
add a comment

Dane Street Client Logo (M0739750xB1386)Firm client Dane Street has been named, for the fourth consecutive year, to Boston Business Journal’s (BBJ) 2017 FAST 50 List of Top Fastest Growing Private Companies in Massachusetts. Dane Street provides Independent Medical Examination and Peer Review services to the auto, disability, group health, pharmacy, and workers’ compensation industries.

BBJ’s publisher, Carolyn M. Jones, said “these companies represent the best examples of the Boston economy’s strength and vibrancy”. Companies are included on the list based on revenue growth over the prior three years.

Congratulations to our client! For more information, read the full article.

Boston University Senior Business Lecturer Greg Stoller Shares Top Four Asian Business Trends 03/22/2017

Posted by Morse Barnes-Brown Pendleton in Client News, Corporate.
Tags: , , ,
add a comment

Greg Stoller, a friend of the firm and a senior lecturer at BU’s Questrom School of Business, recently returned from a visit to Asia, which included visits to 10 firms in Shanghai and Hong Kong. Among the insights he gained:

Many of the firms are ditching long-term strategic planning in favor of speed and agility, in order to obtain short-term profits and keep competitors at bay.”

In his article “Four Asian Business Trends Happening in Real Time” Greg shares the top 4 trends he experienced in the way business is conducted in China and its neighbors.

%d bloggers like this: